Pricing

Adial Pharmaceuticals Inc (ADIL)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Cary J. Claiborne
Employees: 20
Web site: adialpharma.com
1180 SEMINOLE TRAIL, SUITE 495, CHARLOTTESVILLE, VA, 22901
434-422-9800
Stock Split History
Date Ratio
2023-08-07 1:25
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available